Please ensure Javascript is enabled for purposes of website accessibility

Hanesbrands Sees Big Opportunity Emerging in Medical Garments

By John Ballard - Updated May 5, 2020 at 8:02AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company expects to make $300 million off sales of face masks this year, but the long-term opportunity could be significantly bigger.

Hanesbrands' (HBI -3.63%) first quarter saw sales and profits plunge over the COVID-19 outbreak. Through mid-March, sales were pacing ahead of management's expectations, but the store closures nationwide caused sales to drop 17% year over year for the quarter. 

While demand for socks and undergarments has taken a hit, Hanesbrands did stumble onto a new business line making face masks and other protective medical garments. Like many other companies, Hanesbrands shifted its manufacturing to make COVID-19 face masks during the quarter. 

It's going so well that CEO Gerald Evans sees a new growth opportunity emerging. "We believe our mask and protective garment business could be a sizable revenue opportunity with growth potential over the next several years," he said. 

A woman wearing a medical face mask while shopping in a grocery store

Image source: Getty Images.

Adapting to new environment

Hanesbrands is currently making more than 320 million cloth face coverings and more than 20 million medical gowns for the U.S. government, but the company is receiving interest from several other parties, as Evans explained: 

Over the past several weeks, we have seen a strong influx of inquiries across a number of geographies from governments, retailers, large corporations, and individual consumers.

Management believes its medical garment program will generate $300 million in sales in 2020, and it will continue to ramp up production to address the need. "Looking forward, there is an expectation that the COVID-19 pandemic will result in more widespread mask usage by consumers and businesses globally," as Evans explained.

Evans said the manufacture of medical garments could grow to become "a substantial contributor of incremental profit and cash flow over the next several years." 

Hanesbrands has a distinct competitive advantage to grow this new business over the long term. The company owns its global manufacturing network, which allows it to quickly shift gears to new clothing products and pursue new opportunities. Perhaps the most important advantage is the trust and value consumers place in the Hanes brand.

Speaking about these advantages during the call, Evans said:

When we look across it, the opportunity to bring a trusted brand like Hanes in combination with innovation and run it through our large-scale production and sell it through our international network, really tells us this is a business to build upon. 

Recovery on the horizon?

Hanes said it will begin ramping production for cotton face masks targeted for consumers and businesses that seek to reopen soon. The company is not giving full-year guidance, but management has tested different scenarios of the economic fallout from this outbreak, and Hanesbrands was found to have plenty of liquidity to survive even if stores remain closed through early October, which would be a worst-case scenario. 

Hanesbrands roughly broke even on the quarter, reporting a net loss of $0.02 per share, but management currently expects the second quarter to be the low point before sales and profit begin improving. However, no one really knows how long it will take consumer discretionary spending to fully recover to pre-COVID-19 levels.

Hanesbrands is taking the necessary steps to remain financially strong, including reducing costs and inventory. Cash from operations improved by $111 million over the year-ago quarter, as a result of cuts to inventory spending, and management expects to generate positive cash flow in the second half of the year. 

With a promising new business opportunity and enough financial stability to get through the economic turbulence, this value stock could potentially be very rewarding from current levels.

John Ballard owns shares of Hanesbrands. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Hanesbrands Inc. Stock Quote
Hanesbrands Inc.
HBI
$11.14 (-3.63%) $0.42

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.